Canada markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.84+0.77 (+1.87%)
At close: 04:00PM EDT
41.84 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
399,266
276,472
869,191
397,664
Other Short Term Investments
1,931,935
1,710,397
1,245,782
1,494,711
Total Cash
2,331,201
1,986,869
2,114,973
1,892,375
Inventory
28,425
22,033
24,806
21,965
Other Current Assets
184,449
168,254
143,374
140,163
Total Current Assets
2,641,853
2,202,694
2,345,049
2,130,707
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
339,698
343,554
298,696
268,456
Accumulated Depreciation
-96,759
-87,716
-102,653
-87,379
Net property, plant and equipment
242,939
255,838
196,043
181,077
Intangible Assets
-
-
29,005
27,937
Other long-term assets
105,280
75,344
70,598
50,034
Total non-current assets
348,219
331,182
266,641
259,048
Total Assets
2,990,072
2,533,876
2,611,690
2,389,755
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
53,163
7,535
3,526
308,809
Accounts Payable
26,027
17,921
11,904
17,199
Taxes payable
2,151
6,249
36
1,324
Accrued liabilities
147,894
140,101
88,560
90,161
Deferred revenues
151,128
90,577
97,714
108,376
Other Current Liabilities
-
-
3,526
7,301
Total Current Liabilities
448,090
311,561
240,550
598,898
Non-current liabilities
Long Term Debt
1,229,501
1,182,719
1,228,092
600,120
Deferred revenues
241,184
287,768
351,879
424,046
Other long-term liabilities
513,736
-
26,378
23,409
Total non-current liabilities
2,155,296
1,649,428
1,599,403
1,047,575
Total Liabilities
2,603,386
1,960,989
1,839,953
1,646,473
Stockholders' Equity
Common Stock
144
142
141
140
Retained Earnings
-1,795,911
-1,429,625
-1,159,903
-1,131,306
Accumulated other comprehensive income
-32,645
-57,480
-32,668
-21,071
Total stockholders' equity
386,686
572,887
771,737
743,282
Total liabilities and stockholders' equity
2,990,072
2,533,876
2,611,690
2,389,755